Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review
- PMID: 31535327
- PMCID: PMC6856250
- DOI: 10.1007/s40121-019-00264-7
Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review
Abstract
Infants are vulnerable to pertussis infection particularly before initiation of pertussis vaccination. Maternal pertussis vaccination during pregnancy has been introduced in a number of countries in order to confer on young infants indirect protection from the disease through transplacental transfer of maternal antibodies. We reviewed the evidence on the immunogenicity and efficacy of maternal pertussis vaccination during pregnancy. A systematic search of PubMed/MEDLINE, EMBASE, Scopus, Cochrane Database of Systematic Reviews, ProQuest, and Science Direct was undertaken to identify studies published between January 1995 and December 2018. This review was not specific to any particular pertussis vaccine but included applicable data on available pertussis vaccines administered to pregnant women. The search identified 40 publications for inclusion in this review. Vaccination during pregnancy elicited robust maternal immune responses against all vaccine antigens and resulted in high placental transfer of pertussis antibodies to the infant that persisted well beyond delivery. Vaccination during the second or early third trimesters was considered ideal for antibody quantity and functionality. Although blunting of immune responses to some antigens in the primary immunization series was documented in neonates born to women vaccinated during pregnancy, there was no apparent adverse effect on vaccine efficacy. Multiple studies conducted in diverse settings have confirmed the effectiveness of maternal pertussis vaccination during pregnancy in preventing pertussis in infants prior to receipt of their first primary vaccine dose and beyond. These findings collectively underscore the value of maternal pertussis vaccination during pregnancy in protecting vulnerable infants too young to be vaccinated.Funding Sanofi Pasteur.Plain Language Summary Plain language summary available for this article.
Keywords: Efficacy; Immunization; Pertussis; Pregnancy.
Conflict of interest statement
Charlotte Switzer is an employee of Sanofi Pasteur. Caroline D’Heilly is an employee of Sanofi Pasteur. Denis Macina is an employee of Sanofi Pasteur.
Figures
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis.Expert Rev Vaccines. 2020 Jul;19(7):621-638. doi: 10.1080/14760584.2020.1791092. Epub 2020 Aug 9. Expert Rev Vaccines. 2020. PMID: 32772755
-
Safety of Maternal Immunization Against Pertussis: A Systematic Review.Infect Dis Ther. 2019 Dec;8(4):543-568. doi: 10.1007/s40121-019-00265-6. Epub 2019 Sep 17. Infect Dis Ther. 2019. PMID: 31531826 Free PMC article. Review.
-
Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial.Clin Infect Dis. 2020 Jun 24;71(1):72-80. doi: 10.1093/cid/ciz778. Clin Infect Dis. 2020. PMID: 31418814 Clinical Trial.
-
Review of vaccination in pregnancy to prevent pertussis in early infancy.J Med Microbiol. 2018 Oct;67(10):1426-1456. doi: 10.1099/jmm.0.000829. Epub 2018 Sep 17. J Med Microbiol. 2018. PMID: 30222536 Review.
Cited by
-
Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland.Immun Inflamm Dis. 2024 Apr;12(4):e1257. doi: 10.1002/iid3.1257. Immun Inflamm Dis. 2024. PMID: 38661110 Free PMC article.
-
Maternal hybrid immunity and risk of infant COVID-19 hospitalizations: national case-control study in Israel.Nat Commun. 2024 Apr 2;15(1):2846. doi: 10.1038/s41467-024-46694-x. Nat Commun. 2024. PMID: 38565530 Free PMC article.
-
All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?Vaccines (Basel). 2024 Jan 18;12(1):97. doi: 10.3390/vaccines12010097. Vaccines (Basel). 2024. PMID: 38250910 Free PMC article. Review.
-
Impact of national recommendations for routine pertussis vaccination during pregnancy on infant pertussis in Ontario, Canada: a population-based time-series study.BMC Pregnancy Childbirth. 2023 Aug 31;23(1):627. doi: 10.1186/s12884-023-05938-2. BMC Pregnancy Childbirth. 2023. PMID: 37653488 Free PMC article.
-
Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring.JCI Insight. 2023 Sep 22;8(18):e167210. doi: 10.1172/jci.insight.167210. JCI Insight. 2023. PMID: 37581930 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources